491 related articles for article (PubMed ID: 15536109)
1. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
[TBL] [Abstract][Full Text] [Related]
2. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
Phillips RA; Fonseca V; Katholi RE; McGill JB; Messerli FH; Bell DS; Raskin P; Wright JT; Iyengar M; Anderson KM; Lukas MA; Bakris GL;
J Cardiometab Syndr; 2008; 3(4):211-7. PubMed ID: 19040589
[TBL] [Abstract][Full Text] [Related]
3. Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
Wright JT; Bakris GL; Bell DS; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Holdbrook FK; Lukas MA; Iyengar M
J Clin Hypertens (Greenwich); 2007 Nov; 9(11):842-9. PubMed ID: 17978591
[TBL] [Abstract][Full Text] [Related]
4. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
Bell DS; Bakris GL; McGill JB
Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli F; Phillips RA; Raskin P; Wright JT; Waterhouse B; Lukas MA; Anderson KM; Bell DS;
Hypertension; 2005 Dec; 46(6):1309-15. PubMed ID: 16286578
[TBL] [Abstract][Full Text] [Related]
6. Beta-blockers have a beneficial effect upon endothelial function and microalbuminuria in African-American subjects with diabetes and hypertension.
Jawa A; Nachimuthu S; Pendergrass M; Asnani S; Fonseca V
J Diabetes Complications; 2008; 22(5):303-8. PubMed ID: 18413195
[TBL] [Abstract][Full Text] [Related]
7. Body weight changes with beta-blocker use: results from GEMINI.
Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
[TBL] [Abstract][Full Text] [Related]
8. beta-blocker use and diabetes symptom score: results from the GEMINI study.
McGill JB; Bakris GL; Fonseca V; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Iyengar M; Anderson KM; Lukas MA; Dalal MR; Bell DS
Diabetes Obes Metab; 2007 May; 9(3):408-17. PubMed ID: 17391169
[TBL] [Abstract][Full Text] [Related]
9. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
Bakris GL; Bell DS; Fonseca V; Katholi R; McGill J; Phillips R; Raskin P; Wright JT; Iyengar M; Holeslaw T; Anderson KM;
J Diabetes Complications; 2005; 19(2):74-9. PubMed ID: 15745836
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
Fonseca V; Bakris GL; Bell DS; McGill JB; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Waterhouse B; Lukas MA; Anderson KM;
Diabet Med; 2007 Jul; 24(7):759-63. PubMed ID: 17451422
[TBL] [Abstract][Full Text] [Related]
11. [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].
Frese T; Sandholzer H
Dtsch Med Wochenschr; 2007 Nov; 132(44):2330-1. PubMed ID: 17957597
[TBL] [Abstract][Full Text] [Related]
12. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
Sica DA
J Clin Hypertens (Greenwich); 2005 Jan; 7(1):59-64. PubMed ID: 15655391
[No Abstract] [Full Text] [Related]
13. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
Fardoun RZ
Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
[TBL] [Abstract][Full Text] [Related]
14. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
17. Influence of carvedilol on blood glucose and glycohaemoglobin A1 in non-insulin-dependent diabetics.
Ehmer B; van der Does R; Rudorf J
Drugs; 1988; 36 Suppl 6():136-40. PubMed ID: 2908300
[TBL] [Abstract][Full Text] [Related]
18. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.
Poole-Wilson PA; Swedberg K; Cleland JG; Di Lenarda A; Hanrath P; Komajda M; Lubsen J; Lutiger B; Metra M; Remme WJ; Torp-Pedersen C; Scherhag A; Skene A;
Lancet; 2003 Jul; 362(9377):7-13. PubMed ID: 12853193
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
20. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]